Shijiazhuang Yiling Pharmaceutical Co., Ltd.

SZSE:002603 Voorraadrapport

Marktkapitalisatie: CN¥28.1b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Shijiazhuang Yiling Pharmaceutical Beheer

Beheer criteriumcontroles 2/4

De CEO Shijiazhuang Yiling Pharmaceutical's is Xiang Jun Wu, benoemd in Apr2013, heeft een ambtstermijn van 11.5 jaar. bezit rechtstreeks 20.81% van de aandelen van het bedrijf, ter waarde CN¥ 6.27B. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 11.5 jaar en 7.8 jaar.

Belangrijke informatie

Xiang Jun Wu

Algemeen directeur

CN¥3.2m

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO11.5yrs
Eigendom CEO20.8%
Management gemiddelde ambtstermijn11.5yrs
Gemiddelde ambtstermijn bestuur7.8yrs

Recente managementupdates

Recent updates

Is Shijiazhuang Yiling Pharmaceutical (SZSE:002603) Using Too Much Debt?

Sep 25
Is Shijiazhuang Yiling Pharmaceutical (SZSE:002603) Using Too Much Debt?

Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s (SZSE:002603) Subdued P/S Might Signal An Opportunity

Aug 07
Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s (SZSE:002603) Subdued P/S Might Signal An Opportunity

Shijiazhuang Yiling Pharmaceutical (SZSE:002603) Has Announced That Its Dividend Will Be Reduced To CN¥0.30

Jul 15
Shijiazhuang Yiling Pharmaceutical (SZSE:002603) Has Announced That Its Dividend Will Be Reduced To CN¥0.30

Is Shijiazhuang Yiling Pharmaceutical (SZSE:002603) A Risky Investment?

May 26
Is Shijiazhuang Yiling Pharmaceutical (SZSE:002603) A Risky Investment?

Weak Statutory Earnings May Not Tell The Whole Story For Shijiazhuang Yiling Pharmaceutical (SZSE:002603)

May 05
Weak Statutory Earnings May Not Tell The Whole Story For Shijiazhuang Yiling Pharmaceutical (SZSE:002603)

Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SZSE:002603) Analysts Just Cut Their EPS Forecasts Substantially

May 02
Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SZSE:002603) Analysts Just Cut Their EPS Forecasts Substantially

Should You Be Adding Shijiazhuang Yiling Pharmaceutical (SZSE:002603) To Your Watchlist Today?

Mar 01
Should You Be Adding Shijiazhuang Yiling Pharmaceutical (SZSE:002603) To Your Watchlist Today?

CEO

Xiang Jun Wu (49 yo)

11.5yrs

Tenure

CN¥3,154,300

Compensatie

Mr. Xiang Jun Wu served as Deputy General Manager and Shijiazhuang Yiling Pharmaceutical Co., Ltd. and had been its Marketing Center General manager Since 2005. He is a Director since August 31, 2010 and G...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Xiang Jun Wu
Chairman & GM11.5yrsCN¥3.15m20.81%
CN¥ 5.8b
Chen Guang Li
CFO & Director6.5yrsCN¥1.83mgeen gegevens
Wei Wang
Deputy GM & Director of Administrative Center13.8yrsCN¥944.90k0.12%
CN¥ 33.8m
Wei Dong Xu
Executive Deputy Director of the Human Resources Center & Directorno dataCN¥939.10k0.017%
CN¥ 4.8m
Rui Wu
Secretary of the Board & Non-Independent Director14.2yrsCN¥1.83m2.34%
CN¥ 656.8m
Qiu Lian Zhang
Deputy GM & Non-Independent Directorno dataCN¥2.16m0.017%
CN¥ 4.8m
Xiaolin Zhou
Deputy GM & Director of the Supply Center1.7yrsCN¥1.41m0.032%
CN¥ 8.9m

11.5yrs

Gemiddelde duur

54yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 002603 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 11.5 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Xiang Jun Wu
Chairman & GM14.2yrsCN¥3.15m20.81%
CN¥ 5.8b
Chen Guang Li
CFO & Director6.4yrsCN¥1.83mgeen gegevens
Wei Dong Xu
Executive Deputy Director of the Human Resources Center & Director4.8yrsCN¥939.10k0.017%
CN¥ 4.8m
Rui Wu
Secretary of the Board & Non-Independent Director7.8yrsCN¥1.83m2.34%
CN¥ 656.8m
Qiu Lian Zhang
Deputy GM & Non-Independent Director4.8yrsCN¥2.16m0.017%
CN¥ 4.8m
Xue Dong Gao
Chairman of the Supervisory Board10.2yrsgeen gegevens0.074%
CN¥ 20.8m
Shao Hua Zhao
Director11.5yrsCN¥971.80k0.037%
CN¥ 10.4m
Gen Wu Liu
Supervisor10.2yrsgeen gegevens0.00065%
CN¥ 182.4k
Rui Hua Niu
Supervisor14.2yrsgeen gegevensgeen gegevens
Xiaohan Liu
Independent Director4.8yrsCN¥116.60kgeen gegevens
Gang Chen
Independent Director1.7yrsCN¥100.00kgeen gegevens

7.8yrs

Gemiddelde duur

54yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 002603 wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.8 jaar).